Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-09-11-Speech-2-375-000"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20120911.32.2-375-000"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
"The case in 2011 of the French medicine Mediator and the ensuing medicine safety enquiry in France caused many people to call for an urgent review of pharmacovigilance systems in the European Union. The lessons learned from this case have shown that although new legislation adopted in 2010, which amended pharmacovigilance rules, has brought about a real improvement in pharmacovigilance, there are still certain shortcomings in the EU system which need to be corrected. These considerations led me to endorse the report."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples